Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novartis ADR | NVS | Aug 30, 2024 | 120.89 | +0.39 |
Novavax | NVAX | Aug 30, 2024 | 12.38 | +8.60 |
Novo Integrated Sciences | NVOS | Aug 30, 2024 | 0.31 | -1.47 |
Novo Nordisk ADR | NVO | Aug 30, 2024 | 139.16 | +1.19 |
NovoCure | NVCR | Aug 30, 2024 | 19.44 | -1.57 |
Novonix ADR | NVX | Aug 30, 2024 | 1.69 | +6.29 |
NRG Energy | NRG | Aug 30, 2024 | 85.01 | +2.89 |
NRx Pharmaceuticals | NRXP | Aug 30, 2024 | 1.87 | +2.19 |
NSTS Bancorp | NSTS | Aug 30, 2024 | 9.85 | +0.92 |
Nu Holdings | NU | Aug 30, 2024 | 14.97 | +5.20 |
Nu Skin Enterprises | NUS | Aug 30, 2024 | 8.93 | -3.88 |
Nuburu | BURU | Aug 30, 2024 | 0.91 | -6.48 |
NuCana ADR | NCNA | Aug 30, 2024 | 3.66 | -52.65 |
Nucor | NUE | Aug 30, 2024 | 151.91 | +1.26 |
Nukkleus | NUKK | Aug 30, 2024 | 0.29 | -2.74 |
Nurix Therapeutics | NRIX | Aug 30, 2024 | 25.20 | +0.80 |
NuScale Power | SMR | Aug 30, 2024 | 8.23 | +1.11 |
Nustar Energy A Pref | NS-A | Aug 30, 2024 | 24.99 | 0.00 |
Nustar Energy B Pref | NS-B | Aug 30, 2024 | 24.99 | 0.00 |
Nustar Energy C Pref | NS-C | Aug 30, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Aug 30, 2024 | 63.19 | +0.45 |
Nutex Health | NUTX | Aug 30, 2024 | 21.39 | -2.15 |
Nutriband | NTRB | Aug 30, 2024 | 4.08 | -4.00 |
Nutrien | NTR | Aug 30, 2024 | 48.42 | +0.33 |
Nuvalent A | NUVL | Aug 30, 2024 | 85.13 | -0.43 |
Nuvation Bio A | NUVB | Aug 30, 2024 | 3.22 | +0.63 |
Nuvectis Pharma | NVCT | Aug 30, 2024 | 6.96 | +2.50 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Aug 30, 2024 | 13.02 | +1.01 |
Nuveen Amtfree Municipal Value Fund | NUW | Aug 30, 2024 | 14.02 | +0.07 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Aug 30, 2024 | 11.60 | +0.43 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.